BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
10.42
+0.53 (5.36%)
At close: Mar 6, 2026, 4:00 PM EST
10.62
+0.20 (1.92%)
After-hours: Mar 6, 2026, 7:33 PM EST
BBOT Market Cap
BBOT has a market cap or net worth of $833.94 million as of March 6, 2026. Its market cap has increased by 237.52% in one year.
Market Cap
833.94M
Enterprise Value
411.25M
1-Year Change
237.52%
Ranking
Category
Stock Price
$10.42
Market Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $833.94M, an increase of 2,082.38%. That is a compound annual growth rate of 343.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 833.48M | -16.77% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 871.23M |
| Arvinas | 869.87M |
| Janux Therapeutics | 841.91M |
| Phathom Pharmaceuticals | 840.78M |
| Sana Biotechnology | 840.63M |
| Evommune | 835.39M |
| Xencor | 830.19M |
| KalVista Pharmaceuticals | 820.37M |